⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

May 10, 2007Current Opinion in Lipidology

Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease

View Full Paper

Ask AI

Bookmark

Share

Design

Review

Authors

CLCristina Lara‐CastroPalmetto Health Richland YFYuchang FuChina Medical University BCB H ChungHallym University Kangnam Sacred Heart Hospital

Discussion

Loading...

Member takes

Implication

Adiponectin effects on atherosclerosis need clinical testing; leaves open its viability as a therapeutic target.

Key Points

Key points are not available for this paper at this time.

Cite This Study

Lara‐Castro et al. (2007) studied this question.

synapsesocial.com/papers/6a738d426cf7a6ca1f6c3d74 https://doi.org/10.1097/mol.0b013e32814a645f

View Full Paper

Ask AI

Bookmark

Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1The Relationships of Plasma Adiponectin with a Favorable Lipid Profile, Decreased Inflammation, and Less Ectopic Fat Accumulation Depend on Adiposity2006 · 91 citations
2Adiponectin Receptors in Human Adipose Tissue: Effects of Obesity, Weight Loss, and Fat Depots2006 · 161 citations
3Adiponectin and Coronary Heart Disease2006 · 405 citations
4Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein.1991 · 626 citations
5Contribution of Hepatic Lipase, Lipoprotein Lipase, and Cholesteryl Ester Transfer Protein to LDL and HDL Heterogeneity in Healthy Women2002 · 100 citations